Kertes J, David SSB, Engel-Zohar N, Rosen K, et al. Association between AZD7442 (tixagevimab-cilgavimab) administration and SARS-CoV-2 infection, hospitalization and mortality. Clin Infect Dis 2022 Jul 29. pii: 6651663. doi: 10.1093.
PMID: 35904210